CB1 receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration
- 9 November 2024
- journal article
- research article
- Published by Elsevier in Progress in Neurobiology
- Vol. 243, 102683
Abstract
No abstract availableKeywords
Funding Information
- Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques (ARSEP-1310)
- Instituto de Salud Carlos III (PI21/00629)
- Fundación Tatiana Pérez de Guzmán el Bueno
- Ministerio de Economía y Competitividad (CNS2022-135321)
- Ministerio de Economía y Competitividad (PID2020-112640RB-I00)
- Ministerio de Ciencia e Innovación (SAF2016-75292-R)
- Ministerio de Ciencia e Innovación (PID2021-125118OB-I00)
- Comunidad de Madrid (2020-5 A/BMD-19728)
- Federación Española de Enfermedades Raras
- Eusko Jaurlaritza (PIBA_2023_1_0046)
- Eusko Jaurlaritza (IT1203-19)
- Eusko Jaurlaritza (IT1473-22)
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CB06/0005/0076)
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CB06/05/0005)
This publication has 60 references indexed in Scilit:
- Endocannabinoid signaling in microgliaGlia, 2022
- A Critical Review of White Matter Changes in Huntington’s DiseaseMovement Disorders, 2020
- 2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditionsGlia, 2020
- NG2‐glia and their functions in the central nervous systemGlia, 2015
- Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane‐anchored EGFPGenesis, 2014
- The translational biology of remyelination: Past, present, and futureGlia, 2014
- Differential distribution of diacylglycerol lipase‐alpha and N‐acylphosphatidylethanolamine‐specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of ratsGlia, 2012
- Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiationGlia, 2011
- Targeting Oligodendrocyte Protection and Remyelination in Multiple SclerosisMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011
- Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to DisabilityArchives of Neurology, 2001